Gastrointestinal Stromal Tumors: Causes, Risk Factors, Symptoms, Treatment
For Appointments
040 6700 0000
Emergency
040 6700 0111

Gastrointestinal Stromal Tumors (GIST)

Gastrointestinal Stromal Tumors (GISTs) are a type of rare cancer that develops in the gastrointestinal tract. These tumors arise from specialized cells in the wall of the digestive system called interstitial cells of Cajal (ICCs). GISTs can occur anywhere along the GI tract, but they are most commonly found in the stomach or small intestine. GISTs are often difficult to diagnose because their symptoms can be vague and nonspecific. 

Symptoms of Gastrointestinal Stromal Tumors (GIST)

If you suspect you or someone else is experiencing Gastrointestinal Stromal Tumors, it is crucial to seek immediate medical attention by calling emergency services or consult with a Cancer Specialist.

Causes of Gastrointestinal Stromal Tumors (GIST)

  • Genetic Mutations: The most common cause of GISTs is mutations in the KIT gene (which encodes a receptor called KIT or c-Kit), or less commonly, the PDGFRA gene (encoding Platelet-Derived Growth Factor Receptor Alpha).

  • Familial Syndromes:

    • Neurofibromatosis Type 1 (NF1): A genetic disorder that increases the risk of developing GISTs, particularly in the stomach.
    • Carney-Stratakis Syndrome: A rare inherited condition that causes GISTs and other tumors, linked to mutations in SDH genes (succinate dehydrogenase).

  • Age: GISTs are more commonly found in adults, with the average age of diagnosis being 60-65 years. They are rare in children.

  • Gender: GISTs are slightly more common in men than women.

  • Previous Cancer Treatment: Previous exposure to chemotherapy or radiation therapy can increase the risk of GIST development, particularly in those who have undergone treatment for other cancers.

  • Tumor Location: GISTs often occur in the stomach or small intestine, with a smaller percentage occurring in the esophagus, colon, or rectum.

  • Other Genetic Syndromes: Individuals with conditions like von Hippel-Lindau disease or Li-Fraumeni syndrome may have an increased risk.

  • Environmental Factors: While less understood, certain environmental factors or lifestyle habits might contribute to the risk, although no direct link has been definitively established.

Risk Factors of Gastrointestinal Stromal Tumors (GIST)

  • Age (50-70 years)
  • Genetic mutations (KIT, PDGFRA)
  • Family history (NF1, GIST syndrome)
  • Previous cancer treatments
  • Gender (more common in men)
  • Specific conditions (Carney-Stratakis syndrome)

Symptoms of Gastrointestinal Stromal Tumors (GIST)

  • Abdominal Pain or Discomfort: A common symptom, especially if the tumor is large or growing.

  • Unexplained Weight Loss: Loss of appetite and weight loss may occur as a result of the tumor or its effects on digestion.

  • Nausea and Vomiting: These symptoms may develop if the tumor causes an obstruction or irritation in the digestive tract.

  • Bloating or Feeling Full: Tumors in the stomach or small intestine can cause a sensation of fullness or bloating, even after eating small amounts of food.

  • Bleeding in the GI Tract:

    • Black or Tarry Stools: Indicating gastrointestinal bleeding.
    • Vomiting Blood: This can occur if the tumor ulcerates or bleeds into the stomach or intestines.

  • Anemia: Due to chronic bleeding, which may result in symptoms like fatigue, weakness, and pale skin.

  • Palpable Abdominal Mass: In some cases, the tumor may be large enough to be felt as a mass in the abdomen.

  • Difficulty Swallowing: If the tumor is located in the esophagus, it may cause swallowing difficulties (dysphagia).

  • Obstruction of the Bowel: In rare cases, GISTs can lead to bowel obstruction, resulting in symptoms like cramping, constipation, or inability to pass gas.

  • Fever: Uncommon but may be seen in some individuals, particularly if the tumor has spread (metastasized).

  • Fatigue: Often due to anemia or the general burden of the tumor.

Need an Appointment?

Diagnosis for Gastrointestinal Stromal Tumors (GIST)

  • Medical History & Physical Exam: Review symptoms and check for abdominal masses.
  • CT Scan: Identifies tumor size, location, and spread.
  • MRI: Provides detailed images, especially for stomach or liver tumors.
  • Endoscopic Ultrasound (EUS): Visualizes tumors in the stomach or duodenum.
  • Upper GI Endoscopy: Examines the stomach and small intestine, with potential biopsy.
  • Colonoscopy: Used for tumors in the colon.
  • Biopsy: Fine Needle Aspiration (FNA) or Core Needle Biopsy to obtain tissue samples.
  • Genetic Testing: Identifies KIT or PDGFRA mutations.
  • Immunohistochemistry (IHC): Detects specific proteins like c-Kit.
  • Blood Tests: Checks for anemia or other health issues.
  • Laparoscopy: Surgical procedure to view and biopsy tumors.

Treatments for Gastrointestinal Stromal Tumors (GIST)

  • Surgical Resection: The primary treatment for localized GISTs; involves removing the tumor and surrounding tissue.

  • Targeted Therapy (Imatinib): The first-line treatment for advanced or metastatic GISTs; works by targeting the KIT or PDGFRA mutations in the tumor cells.

  • Sunitinib (Sutent): A second-line treatment for patients who don’t respond to imatinib, used for advanced GISTs.

  • Radiation Therapy: Rarely used, but may be considered for palliative care or in cases where surgery isn’t an option.

  • Chemotherapy: Typically not effective for GISTs, but may be used in combination with other treatments for some advanced cases.

  • Immunotherapy: Experimental treatments being studied for their effectiveness in treating GISTs.

  • Laparoscopic Surgery: Minimally invasive surgery option for smaller or less complex tumors.

  • Follow-up Care: Regular imaging and monitoring for recurrence, especially in high-risk cases.

Preventive Measures for Gastrointestinal Stromal Tumors (GIST)

  • Genetic Counseling: For individuals with a family history of conditions like Neurofibromatosis or Carney-Stratakis Syndrome, genetic counseling may help assess the risk of GISTs and guide early screening.

  • Regular Screening for High-Risk Individuals: Individuals with inherited conditions (e.g., NF1 or Carney-Stratakis Syndrome) may benefit from routine imaging (e.g., CT scans) to detect tumors early.

  • Monitoring in Family Members: Family members of individuals with hereditary GISTs or related syndromes may be monitored regularly to detect any signs of the disease.

  • Healthy Lifestyle: While there’s no direct evidence linking lifestyle choices to GIST prevention, maintaining a healthy diet and weight, and avoiding smoking or excessive alcohol may contribute to overall well-being and reduce cancer risk.

  • Avoiding Radiation Exposure: Limiting exposure to unnecessary radiation, especially for those with a history of radiation therapy, can reduce the potential risk of GISTs.

  • Early Detection: Awareness of symptoms (such as unexplained abdominal pain, weight loss, and gastrointestinal bleeding) can lead to early diagnosis and improved treatment outcomes.

Do's & Don’t's

When it comes to dealing with gastrointestinal stromal tumors (GISTs), there are certain do's and don'ts that can help in managing the condition effectively. By following these guidelines, patients and their caregivers can ensure better outcomes and improve their quality of life. 

Do's Don't
Do: Follow your healthcare provider's treatment plan. Don't: Neglect regular medical check-ups and appointments.
Do: Maintain a balanced and nutritious diet. Don't: Consume excessive amounts of processed foods or high-fat content.
Do: Stay hydrated by drinking an adequate amount of water. Don't: Overconsume alcohol or caffeinated beverages.
Do: Engage in regular, moderate exercise with your healthcare provider's approval. Don't: Participate in strenuous activities without medical clearance.
Do: Report any unusual symptoms or side effects to your healthcare team promptly. Don't: Delay seeking medical attention if you experience new or worsening symptoms.
Do: Manage stress through relaxation techniques like deep breathing or meditation. Don't: Ignore the importance of mental health; seek support if needed.
Do: Take prescribed medications as directed by your healthcare provider. Don't: Adjust medication doses or stop them without consulting your doctor.
Do: Communicate openly with your healthcare team about your concerns and questions. Don't: Hesitate to seek a second opinion if you have doubts about your diagnosis or treatment plan.
Do: Educate yourself about GISTs and ask questions during medical appointments. Don't: Rely solely on unverified information from non-medical sources.
Do: Practice good hygiene to prevent infections, especially if undergoing treatment. Don't: Neglect proper hygiene practices, which are crucial during cancer treatment.

If you suspect you or someone else is experiencing Gastrointestinal Stromal Tumors, it is crucial to seek immediate medical attention by calling emergency services or consult with a Cancer Specialist.

Frequently Asked Questions
Gastrointestinal Stromal Tumors (GISTs) are a type of rare cancer that develops in the gastrointestinal tract. These tumors arise from specialized cells in the wall of the digestive system called interstitial cells of Cajal (ICCs). GISTs can occur anywhere along the GI tract, but they are most commonly found in the stomach or small intestine.
One of the primary causes of GISTs is believed to be genetic mutations. Research has shown that certain gene mutations, such as those in the KIT or PDGFRA genes, can lead to the development of GISTs. These mutations can disrupt normal cell growth and division, resulting in the formation of tumors.
One significant risk factor is age. GISTs are more commonly diagnosed in adults over the age of 40, with the risk increasing as individuals get older. Additionally, gender may play a role, as men are slightly more prone to developing GISTs than women.
One of the most common symptoms of GISTs is abdominal pain or discomfort. This pain may be persistent or intermittent and can vary in intensity. Some individuals may also experience a feeling of fullness or bloating in the abdomen.
One of the primary methods used for GIST diagnosis is imaging studies, such as computed tomography (CT) scans and magnetic resonance imaging (MRI). These imaging techniques allow physicians to visualize the tumor's location, size, and potential involvement with surrounding structures. Additionally, endoscopic ultrasound (EUS) can provide detailed images of the gastrointestinal tract, aiding in the detection and characterization of GISTs.
Surgical resection is often the first line of defense against GISTs, with the goal of removing the tumor and any surrounding affected tissue. However, depending on the size and location of the tumor, surgery alone may not be sufficient. In such cases, targeted therapies have emerged as a promising option.
One of the primary preventive measures is maintaining a healthy lifestyle. This includes adopting a balanced diet rich in fruits, vegetables, whole grains, and lean proteins. Avoiding processed foods, excessive red meat consumption, and high-fat diets may also be beneficial in reducing the risk of developing GISTs.